A multi-biomarker follow-up study of patients with multiple sclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multi-biomarker follow-up study of patients with multiple sclerosis
Authors
Keywords
-
Journal
Brain and Behavior
Volume 6, Issue 9, Pages e00509
Publisher
Wiley
Online
2016-07-11
DOI
10.1002/brb3.509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients
- (2015) Madlyne Becker et al. BMC Neurology
- Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery
- (2015) Konstantin Kazankov et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
- (2015) Morten Stilund et al. PLoS One
- Prediction of response to interferon therapy in multiple sclerosis
- (2014) F. Sellebjerg et al. ACTA NEUROLOGICA SCANDINAVICA
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
- (2014) Morten Stilund et al. PLoS One
- Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-αAntibody Treatment in Active Inflammatory Bowel Disease
- (2014) A. Dige et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
- (2013) J. Kuhle et al. ACTA NEUROLOGICA SCANDINAVICA
- Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study
- (2013) Roberto D’Alessandro et al. JOURNAL OF NEUROLOGY
- Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
- (2013) Trygve Holmøy et al. PLoS One
- Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!)
- (2012) Mark S Freedman Multiple Sclerosis Journal
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
- (2011) Zhiren Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- How long can you keep working with benign multiple sclerosis?
- (2010) S. B. Glad et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event
- (2010) Olivier Gout et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- In Vivo Exposure to High or Low Cortisol Has Biphasic Effects on Inflammatory Response Pathways of Human Monocytes
- (2008) Mark P. Yeager et al. ANESTHESIA AND ANALGESIA
- A multifactorial prognostic index in multiple sclerosis
- (2008) J. Mandrioli et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now